Besides the regulation of normal hematopoiesis, low-level or loss of Gfi1b promotes AML development and negatively influences the prognosis of myelodysplastic syndrome (MDS)/AML patients [15]. The gene discussed is GFI1B; the disease is acute myeloid leukemia.